Ken Wong is Director of the USC Mann Division of Healthcare and Biopharmaceutical Business and an Associate Professor in the Department of Pharmaceutical and Health Economics. The division includes the Healthcare Decision Analysis and Biopharmaceutical Marketing graduate programs. He also serves as a Senior Scholar at the USC Leonard D. Schaeffer Center for Health Policy & Economics.
Dr. Wong leads USC Mann’s Global Access to Innovative Medicines Initiative, which advances equitable access to innovative medicines in emerging markets and low- and middle-income countries through education and leadership development, research and scholarship, and global engagement. His research examines the policies and strategies that shape the affordability and availability of medicines in these settings.
Dr. Wong brings experience in both the pharmaceutical and health insurance industries to his academic work. At Novartis Pharmaceuticals, he held leadership positions in Health Economics and Outcomes Research and Managed Healthcare. Earlier in his career, he served in pharmacy leadership roles with Cigna, Caremark, and UniHealth. As an accreditation surveyor for the Joint Commission, he advised healthcare systems on pharmaceutical and quality-of-care standards.
He earned his Doctor of Pharmacy degree from the University of Southern California, Master of Public Health from the University of Massachusetts Amherst, and bachelor’s degree from UCLA.